Laser affords multiple uses, benefits

Article

A specific diode laser is the latest technology to perform several different laser procedures in the ophthalmic practice. Its multi-use capabilities for glaucoma and retinal disease make it a strong choice for the office setting.

A specific diode laser (IQ 810, Iridex Corp.), with its versatility, is one of the latest technologies available for laser trabeculoplasty. Micropulse laser trabeculoplasty (MLT) is a tissue-sparing laser technology that allows fine control of the thermal effects of the laser to minimize thermal spread and collateral damage in the trabecular meshwork.

MLT, similar to selective laser trabeculoplasty (SLT), causes no damage in the eye, compared with argon laser trabeculoplasty (ALT).

Choosing this diode laser was an important part of practice management in his multispeciality group practice, Dr Lish said. He and his colleagues had used a solid-state laser (Coherent) that performed multiple tasks required by a glaucoma specialist and a retina specialist.

When the practice needed a new laser with multifunctional capabilities, his research into various lasers led him to opt for the proprietary 810 nm laser system.

He cited studies published by Fudemberg et al.1 and Saunders et al.,2 who demonstrated that the MLT laser, as well as the SLT laser, did not cause coagulative damage to the trabecular meshwork compared with ALT. This information was important in his choice of the 810 nm laser, which was substantially less expensive than an SLT model and was able to perform all the functions of the practice's ageing laser.

Two other practical advantages, he added, are that the MLT laser is small and portable.

"I found that [while] using the MLT laser, my patients were more comfortable, with less inflammation and no formation of synechiae," said Dr Lish, a clinical instructor at Mount Sinai Medical Center, New York, USA, and a community glaucoma specialist in Brooklyn, New York, USA. "This was in contrast to the argon laser, which is associated with rates of anterior synechiae formation from 30% to 40%."

He added that MLT is equal in efficacy to ALT and SLT.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
© 2025 MJH Life Sciences

All rights reserved.